Galapagos (GLPG) Competitors $28.35 +0.04 (+0.14%) Closing price 04:00 PM EasternExtended Trading$28.37 +0.02 (+0.07%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GLPG vs. RVMD, VRNA, BBIO, ELAN, GRFS, TLX, TGTX, NUVL, LEGN, and LNTHShould you be buying Galapagos stock or one of its competitors? The main competitors of Galapagos include Revolution Medicines (RVMD), Verona Pharma (VRNA), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), Grifols (GRFS), Telix Pharmaceuticals Limited American Depositary Shares (TLX), TG Therapeutics (TGTX), Nuvalent (NUVL), Legend Biotech (LEGN), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry. Galapagos vs. Revolution Medicines Verona Pharma BridgeBio Pharma Elanco Animal Health Grifols Telix Pharmaceuticals Limited American Depositary Shares TG Therapeutics Nuvalent Legend Biotech Lantheus Galapagos (NASDAQ:GLPG) and Revolution Medicines (NASDAQ:RVMD) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, community ranking, analyst recommendations, institutional ownership, media sentiment, profitability and earnings. Does the MarketBeat Community prefer GLPG or RVMD? Galapagos received 363 more outperform votes than Revolution Medicines when rated by MarketBeat users. However, 78.03% of users gave Revolution Medicines an outperform vote while only 63.75% of users gave Galapagos an outperform vote. CompanyUnderperformOutperformGalapagosOutperform Votes46663.75% Underperform Votes26536.25% Revolution MedicinesOutperform Votes10378.03% Underperform Votes2921.97% Does the media refer more to GLPG or RVMD? In the previous week, Galapagos had 1 more articles in the media than Revolution Medicines. MarketBeat recorded 2 mentions for Galapagos and 1 mentions for Revolution Medicines. Galapagos' average media sentiment score of 1.72 beat Revolution Medicines' score of 0.94 indicating that Galapagos is being referred to more favorably in the media. Company Overall Sentiment Galapagos Very Positive Revolution Medicines Positive Do analysts rate GLPG or RVMD? Galapagos currently has a consensus price target of $25.33, suggesting a potential downside of 11.24%. Revolution Medicines has a consensus price target of $67.08, suggesting a potential upside of 60.38%. Given Revolution Medicines' stronger consensus rating and higher probable upside, analysts clearly believe Revolution Medicines is more favorable than Galapagos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Galapagos 4 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is GLPG or RVMD more profitable? Galapagos' return on equity of 0.00% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets GalapagosN/A N/A N/A Revolution Medicines N/A -33.67%-30.08% Which has higher earnings and valuation, GLPG or RVMD? Galapagos has higher revenue and earnings than Revolution Medicines. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGalapagos$288.19M6.53$80.16MN/AN/ARevolution Medicines$742K10,500.04-$436.37M-$4.00-10.46 Do insiders and institutionals have more ownership in GLPG or RVMD? 32.5% of Galapagos shares are held by institutional investors. Comparatively, 94.3% of Revolution Medicines shares are held by institutional investors. 2.9% of Galapagos shares are held by insiders. Comparatively, 8.2% of Revolution Medicines shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, GLPG or RVMD? Galapagos has a beta of 0.07, suggesting that its share price is 93% less volatile than the S&P 500. Comparatively, Revolution Medicines has a beta of 1.1, suggesting that its share price is 10% more volatile than the S&P 500. SummaryRevolution Medicines beats Galapagos on 8 of the 15 factors compared between the two stocks. Get Galapagos News Delivered to You Automatically Sign up to receive the latest news and ratings for GLPG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GLPG vs. The Competition Export to ExcelMetricGalapagosPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.88B$6.88B$5.60B$8.68BDividend YieldN/A2.49%5.27%4.19%P/E RatioN/A8.9327.3320.20Price / Sales6.53264.41417.24161.05Price / CashN/A65.8538.2534.64Price / Book0.606.677.124.75Net Income$80.16M$143.49M$3.23B$247.80M7 Day Performance-0.28%5.04%3.59%2.78%1 Month Performance12.72%15.50%13.12%10.13%1 Year Performance8.93%6.19%32.28%15.59% Galapagos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GLPGGalapagos0.7867 of 5 stars$28.35+0.1%$25.33-10.6%+7.2%$1.87B$288.19M0.001,310Positive NewsRVMDRevolution Medicines4.1706 of 5 stars$40.65+3.2%$67.08+65.0%+5.3%$7.57B$742,000.00-11.32250VRNAVerona Pharma2.4557 of 5 stars$84.10+3.6%$82.13-2.3%+586.0%$6.82B$118.54M-43.8030Trending NewsAnalyst ForecastAnalyst RevisionBBIOBridgeBio Pharma4.5446 of 5 stars$35.46+3.5%$57.09+61.0%+44.1%$6.73B$127.42M-12.44400Analyst ForecastAnalyst RevisionELANElanco Animal Health1.1316 of 5 stars$13.440.0%$15.17+12.9%-21.7%$6.67B$4.43B33.599,800Positive NewsGRFSGrifols2.8591 of 5 stars$8.30-0.1%N/A+26.9%$5.71B$7.21B7.0926,300TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.80-1.1%$22.00+31.0%N/A$5.68B$783.21M0.00N/APositive NewsTGTXTG Therapeutics3.0015 of 5 stars$35.75+1.8%$40.80+14.1%+148.0%$5.68B$386.39M-357.46290Positive NewsAnalyst RevisionNUVLNuvalent2.1205 of 5 stars$77.18+3.4%$115.50+49.7%-0.7%$5.54BN/A-22.2440LEGNLegend Biotech3.0586 of 5 stars$29.32+1.3%$76.20+159.9%-17.3%$5.39B$728.30M-30.861,070Short Interest ↑Analyst RevisionLNTHLantheus4.426 of 5 stars$77.13+2.1%$132.67+72.0%+1.4%$5.34B$1.54B12.83700 Related Companies and Tools Related Companies RVMD Competitors VRNA Competitors BBIO Competitors ELAN Competitors GRFS Competitors TLX Competitors TGTX Competitors NUVL Competitors LEGN Competitors LNTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GLPG) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galapagos NV Please log in to your account or sign up in order to add this asset to your watchlist. Share Galapagos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GLPG Stock Free GLPG Stock Alerts